3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
7
Motor Activity
5
Rectal Neoplasms
3
Pain, Postoperative
3
Vomiting
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nausea
2
Lung Neoplasms
2
Liver Diseases
2
Leukemia, Myeloid, Acute
2
Fatigue
2
Colorectal Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Ulcer
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Postoperative Cognitive Complications
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Pediatric Brain Tumor
1
Pathologic Processes
1
Papillomavirus Infections
1
Pain
1
Osteolysis
1
Multiple Myeloma
1
Malnutrition
1
Interventions
Paclitaxel
6
pembrolizumab
3
Cisplatin
3
Carboplatin
3
Biopsy
3
adavosertib
2
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
Fulvestrant
2
Doxorubicin
2
ulixertinib
1
tucatinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
selinexor
1
sapanisertib
1
sacituzumab govitecan
1
relugolix
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
niraparib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
dostarlimab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Control Groups
×
1 year
×
Clear all
No trials found.